The benefits of dose reduction are significant, especially for the most radiosensitive patients:
- Paediatric cases
- Young women
- Patients who require regular follow-up exams1
Veo is the next step in GE's commitment to lower-dose CT. Our ASiR* technology offers fast reconstructions and may allow for low-dose imaging - an ideal approach for routine, robust imaging. By pushing the possibilities even further, Veo represents added capability for the most sensitive cases. Veo establishes new rules in the relationship between image quality and dose reduction. Veo can give the clinicians the diagnostic information they need and may allow for it to be done at previously unthinkable low dose. So at an equivalent dose, Veo may deliver dramatically better aspects of image quality3.
1.In clinical practice, the use of Veo & ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.
2. Obtained by EUR-16262 EN, using a chest factor of 0.017*DLP.
3. In clinical practice, the actual level of LCD and spatial resolution and low signal artifact improvement may vary. Consult with a radiologist and a physicist.